Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current issues in fructose metabolism.

R R Henry1, P A Crapo, A W Thorburn

  • 1San Diego Veterans Administration Medical Center, California.

Annual Review of Nutrition
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM-INSULIN trial.

Diabetes & metabolism·2017
Same author

Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes.

Diabetes, obesity & metabolism·2016
Same author

Improved glucose control with reduced hypoglycaemic risk when linagliptin is added to basal insulin in elderly patients with type 2 diabetes.

Diabetes, obesity & metabolism·2015
Same author

Efficacy, safety and tolerability of aleglitazar in patients with type 2 diabetes: pooled findings from three randomized phase III trials.

Diabetes, obesity & metabolism·2015
Same author

Efficacy and safety of initial combination treatment with sitagliptin and pioglitazone--a factorial study.

Diabetes, obesity & metabolism·2013
Same author

Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial.

Diabetes, obesity & metabolism·2013
Same journal

Mechanisms of NAD+ Homeostasis in Aging and Disease.

Annual review of nutrition·2026
Same journal

Metabolite Damage and Repair in Health and Disease.

Annual review of nutrition·2026
Same journal

From Food to Function: Cross-Kingdom Transfer and Regulatory Potential of Dietary microRNAs Highlighted by Breast Milk.

Annual review of nutrition·2026
Same journal

The Influence of Diet on Cancer Progression and Treatment.

Annual review of nutrition·2026
Same journal

The Potential Physiologic Mechanisms by Which Early-Life Nutrition May Influence Type 2 Diabetes Pathophysiology in Humans.

Annual review of nutrition·2026
Same journal

The Paradox and Future of GLP-1/GIP Combination Therapies: Efficacy and Mechanisms.

Annual review of nutrition·2026
See all related articles

Modest fructose intake shows minimal impact on metabolism for most people. However, large amounts can harm individuals with hypertriglyceridemia or gout.

Area of Science:

  • Nutritional Science
  • Metabolic Research

Background:

  • Increased consumption of refined fructose in North America over 20 years.
  • Unique fructose metabolism prompts research into its health effects.

Purpose of the Study:

  • To evaluate fructose's impact on appetite, exercise, and metabolic diseases.
  • To compare fructose's effects with other sugars.

Main Methods:

  • Literature review on fructose metabolism and health outcomes.
  • Analysis of studies on carbohydrate and lipid metabolism.

Main Results:

  • Little evidence of harm from modest fructose in non-diabetics or NIDDM (non-insulin-dependent diabetes mellitus) subjects.
  • Fructose can significantly raise insulin and triglyceride levels in a subset of NIDDM patients with hypertriglyceridemia.

Related Experiment Videos

  • Large doses may induce hyperuricemia, posing risks for individuals with gout.
  • No clear advantage over glucose for exercise endurance.
  • Insufficient evidence for fructose exacerbating copper deficiency or aiding weight control.
  • Conclusions:

    • Modest fructose intake is generally safe for most individuals regarding carbohydrate and lipid metabolism.
    • Specific populations, including those with hypertriglyceridemia and gout, should limit fructose consumption.
    • Current evidence does not support unique benefits of fructose over other sugars for exercise or weight management.